Home/Pipeline/Biosimilar Darbepoetin Alfa

Biosimilar Darbepoetin Alfa

Anemia of Chronic Kidney Disease

Phase 2Active

Key Facts

Indication

Anemia of Chronic Kidney Disease

Phase

Phase 2

Status

Active

Company

About Biosidus

Argentina‑based biosimilar leader delivering affordable biologics to emerging markets.

View full company profile

Therapeutic Areas

Oncology Rheumatology Endocrinology Immunology